• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Jan 13;11(1):947.
doi: 10.1038/s41598-020-80363-5.
Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning


Alejandro Lopez-Rincon[SUP] 1 [/SUP], Alberto Tonda[SUP] 2 [/SUP], Lucero Mendoza-Maldonado[SUP] 3 [/SUP], Daphne G J C Mulders[SUP] 4 [/SUP], Richard Molenkamp[SUP] 4 [/SUP], Carmina A Perez-Romero[SUP] 5 [/SUP], Eric Claassen[SUP] 6 [/SUP], Johan Garssen[SUP] 7 8 [/SUP], Aletta D Kraneveld[SUP] 7 [/SUP]



Affiliations

Abstract

In this paper, deep learning is coupled with explainable artificial intelligence techniques for the discovery of representative genomic sequences in SARS-CoV-2. A convolutional neural network classifier is first trained on 553 sequences from the National Genomics Data Center repository, separating the genome of different virus strains from the Coronavirus family with 98.73% accuracy. The network's behavior is then analyzed, to discover sequences used by the model to identify SARS-CoV-2, ultimately uncovering sequences exclusive to it. The discovered sequences are validated on samples from the National Center for Biotechnology Information and Global Initiative on Sharing All Influenza Data repositories, and are proven to be able to separate SARS-CoV-2 from different virus strains with near-perfect accuracy. Next, one of the sequences is selected to generate a primer set, and tested against other state-of-the-art primer sets, obtaining competitive results. Finally, the primer is synthesized and tested on patient samples (n = 6 previously tested positive), delivering a sensitivity similar to routine diagnostic methods, and 100% specificity. The proposed methodology has a substantial added value over existing methods, as it is able to both automatically identify promising primer sets for a virus from a limited amount of data, and deliver effective results in a minimal amount of time. Considering the possibility of future pandemics, these characteristics are invaluable to promptly create specific detection methods for diagnostics.
 
Back
Top Bottom